Core One Labs Inc
Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $15.40 million
- Book Value:
- Revenue TTM:
- Operating Margin TTM:
- Gross Profit TTM:
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Core One Labs Inc had its IPO on under the ticker symbol CLABF.
The company operates in the Healthcare sector and Biotechnology industry. Core One Labs Inc has a staff strength of 0 employees.
Shares of Core One Labs Inc opened at $0.33 at the start of the last trading session i.e. 2023-03-28.
The stocks traded within a range of $0.33 - $0.35, and closed at $0.35.
This is a +6.73% increase from the previous day's closing price.
A total volume of 20,117 shares were traded at the close of the day’s session.
In the last one week, shares of Core One Labs Inc have increased by +6.56%.
Core One Labs Inc's Key Ratios
Core One Labs Inc has a market cap of $15.40 million, indicating a price to book ratio of 6.0097 and a price to sales ratio of 30.5409.
In the last 12-months Core One Labs Inc’s revenue was $648088 with a gross profit of $648088 and an EBITDA of $-7868255. The EBITDA ratio measures Core One Labs Inc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Core One Labs Inc’s operating margin was -1221.97% while its return on assets stood at -61.97% with a return of equity of -283.73%.
In Q3, Core One Labs Inc’s quarterly earnings growth was a positive 0% while revenue growth was a negative 38.3%.
Core One Labs Inc’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $-0.3 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Core One Labs Inc’s profitability.
Core One Labs Inc stock is trading at a EV to sales ratio of 28.7148 and a EV to EBITDA ratio of -1.6119. Its price to sales ratio in the trailing 12-months stood at 30.5409.
Core One Labs Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $6.93 million
- Total Liabilities
- $1.56 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Core One Labs Inc ended 2023 with $6.93 million in total assets and $0 in total liabilities. Its intangible assets were valued at $6.93 million while shareholder equity stood at $5.37 million.
Core One Labs Inc ended 2023 with $0 in deferred long-term liabilities, $1.56 million in other current liabilities, 140336628.00 in common stock, $-157855148.00 in retained earnings and $591587.00 in goodwill. Its cash balance stood at $145809.00 and cash and short-term investments were $0. The company’s total short-term debt was $0 while long-term debt stood at $0.
Core One Labs Inc’s total current assets stands at $512509.00 while long-term investments were $0 and short-term investments were $110000.00. Its net receivables were $120210.00 compared to accounts payable of $913133.00 and inventory worth $2097.00.
In 2023, Core One Labs Inc's operating cash flow was $-1.00 while its capital expenditure stood at $1.
Comparatively, Core One Labs Inc paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Core One Labs Inc stock is currently trading at $0.35 per share. It touched a 52-week high of $0.85 and a 52-week low of $0.85. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.42 and 200-day moving average was $0.46 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 57.9% of the company’s stock are held by insiders while 16.8% are held by institutions.
Frequently Asked Questions About Core One Labs Inc
Similar Industry Stocks (Biotechnology)
Core One Labs Inc. operates as a biotechnology research and technology life sciences company. The company focuses on bringing psychedelic medicines to market through novel delivery systems, psychedelic assisted psychotherapy, and API grade psilocybin manufacturing. Its CannaStrips technology produces infused strips that allow for bioavailability of cannabis constituents. The company also offers consulting, financing, and micro cultivation services, as well as operates medical and wellness clinics. In addition, it provides natural health products; and news dissemination services. The company was formerly known as Lifestyle Delivery Systems Inc. and changed its name to Core One Labs Inc. in September 2019. Core One Labs Inc. was incorporated in 2010 and is headquartered in Vancouver, Canada.